Akebia settles all patent disputes with FibroGen and Astellas in EU, UK, Japan

Akebia Therapeutics, Inc.

Settlement covers European (UK) Patent Nos. 2289531, 1463823, 2322155, 1633333, 2322153, 2298301 and Japanese Patent Nos. 4845728, 5474741, 5474872.
Resolves FibroGen's opposition to Akebia's European Patent No. 3357911 before the European Patent Office.
All ongoing litigation in UK courts and Japan Intellectual Property High Court to be terminated under agreement.
No financial terms or other business impact disclosed in the filing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.